南美和中美生物生产市场预测至 2030 年 - 区域分析 - 按产品（生物制剂和生物仿制药、疫苗、细胞和基因疗法、核酸疗法等）、应用（类风湿性关节炎、血液病、癌症、糖尿病、心血管疾病等）、设备（上游设备、下游设备、生物反应器、消耗品和配件）和最终用户（生物制药公司、合同制造组织等）
重磅生物制剂专利到期推动南美和中美生物生产市场发展
生物制剂代表了以前无法治愈的疾病的有希望的新疗法，在制药市场中变得非常重要。原创生物制剂的专利预计将在未来几年到期。
下表给出了最畅销生物制剂的专利和独占权到期日期的估计值。
生物制剂
到期日期
Avastin
2022 年 1 月
Cyramza
2023 年 5 月
Adcetris
2023 年 8 月
Abthrax
2024 年 10 月
Gazyva/Gazyvaro
2024 年 11 月
Darzalex
2026 年 5 月
Ocrevus
2027 年 4 月
Emgality
2028 年 9 月
Hemlibra
2028 年 2 月
Llumetri
2028 年 3 月
Imfinzi
2028 年 9 月
Mylotarg
2028 年 4 月
Imfinzi
2028 年 9 月
Mylotarg
2028 年 4 月
Sylvant
2034 年 7 月
原研生物制品的专利到期和其他知识产权将在未来产生引入新生物仿制药的需求。因此，未来几年市场参与者之间的竞争将加剧。因此，预计重磅生物制剂的专利到期将在预测期内为生物生产市场创造有利可图的机会。
南美和中美生物生产市场概览
南美和中美的生物生产市场细分为巴西、阿根廷和南美和中美其他地区。巴西医疗行业的不断发展和对细胞疗法的认识不断提高，可能会为市场增长创造巨大的增长机会。同样，阿根廷不断发展的医疗保健行业预计将为生物生产市场提供增长机会。
根据《生物材料研究》发表的一篇文章，2020 年，巴西是世界上糖尿病患者人数最多的前十个国家之一，目前排名第五。目前，巴西是全球成人糖尿病 (DM) 患病率最高的第五大国家。根据国际糖尿病联盟 (IDF) 的数据，预计到 2045 年，新发糖尿病病例将增加 54.7%。
据 GaBI 称，2022 年，巴西卫生监管局 (AGência Nacional de Vigilância Sanitária, ANVISA) 批准了 30 种生物仿制药，产品类别包括胰岛素、单克隆抗体、肿瘤坏死因子 (TNF) 抑制剂、人类生长激素、抗凝剂和肝素以及粒细胞集落刺激因子，供巴西使用。ANVISA 批准赛诺菲的 Admelog 生物仿制药在巴西用于治疗糖尿病。因此，巴西糖尿病病例的增加和产品批准的增加正在推动生物生产市场的发展。
南美和中美生物生产市场收入及预测至 2030 年（百万美元）
南美和中美生物生产市场细分
南美和中美生物生产市场分为产品、应用、设备、最终用户和国家。
根据产品，南美和中美生物生产市场细分为生物制剂和生物仿制药、疫苗、细胞和基因疗法、核酸疗法等。生物制剂和生物仿制药部门在 2022 年占据了南美和中美生物生产市场的最大份额。
在应用方面，南美和中美生物生产市场细分为类风湿性关节炎、血液病、癌症、糖尿病、心血管疾病等。癌症部门在 2022 年占据了南美和中美生物生产市场的最大份额。
按设备划分，南美和中美生物生产市场分为上游设备、下游设备、生物反应器以及耗材和配件。耗材和配件部门在 2022 年占据了南美和中美生物生产市场的最大份额。
就最终用户而言，南美和中美生物生产市场分为生物制药公司、合同制造组织和其他。生物制药公司部门在 2022 年占据了南美和中美生物生产市场的最大份额。
按国家划分，南美和中美生物生产市场分为巴西、阿根廷和南美和中美洲其他地区。巴西在 2022 年占据了南美和中美生物生产市场的主导地位。
Lonza Group AG、Danaher Corp、Sartorius AG、Thermo Fisher Scientific Inc、Merck KGaA、F. Hoffmann-La Roche Ltd 和 Bio-Rad Laboratories Inc. 是南美和中美生物生产市场的一些领先公司。
Table of Content
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Bioproduction Market - Key Industry Dynamics
4.1 Market Drivers
4.1.1 Rising Adoption of Regenerative Medicines
4.1.2 Increasing Prevalence of Chronic Diseases
4.2 Market Restraints
4.2.1 High Cost of Cell Therapy and Biosimilar Manufacturing
4.3 Market Opportunities
4.3.1 Patent Expiry of Blockbuster Biologics
4.4 Future Trends
4.4.1 Shift Toward Automated Cell Therapy Manufacturing
4.5 Impact Analysis
5. Bioproduction Market - South & Central America Market Analysis
5.1 South & Central America Bioproduction Market Revenue (US$ Mn), 2020 - 2030
6. South & Central America Bioproduction Market - Revenue and Forecast to 2030 - by Product
6.1 Overview
6.2 South & Central America Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
6.3 Biologics and Biosimilars
6.3.1 Overview
6.3.2 Biologics and Biosimilars: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Vaccines
6.4.1 Overview
6.4.2 Vaccines: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Cell and Gene Therapies
6.5.1 Overview
6.5.2 Cell and Gene Therapies: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Nucleic Acid Therapeutics
6.6.1 Overview
6.6.2 Nucleic Acid Therapeutics: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.7 Others
6.7.1 Overview
6.7.2 Others: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7. South & Central America Bioproduction Market - Revenue and Forecast to 2030 - by Application
7.1 Overview
7.2 South & Central America Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Cancer
7.3.1 Overview
7.3.2 Cancer: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Cardiovascular Diseases
7.4.1 Overview
7.4.2 Cardiovascular Diseases: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Rheumatoid Arthritis
7.5.1 Overview
7.5.2 Rheumatoid Arthritis: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Hematological Disorders
7.6.1 Overview
7.6.2 Hematological Disorders: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Diabetes
7.7.1 Overview
7.7.2 Diabetes: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Bioproduction Market - Revenue and Forecast to 2030 - by Equipment
8.1 Overview
8.2 South & Central America Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
8.3 Consumables and Accessories
8.3.1 Overview
8.3.2 Consumables and Accessories: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Downstream Equipment
8.4.1 Overview
8.4.2 Downstream Equipment: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Bioreactors
8.5.1 Overview
8.5.2 Bioreactors: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.5.2.1 South & Central America: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
8.6 Upstream Equipment
8.6.1 Overview
8.6.2 Upstream Equipment: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Bioproduction Market - Revenue and Forecast to 2030 - by End User
9.1 Overview
9.2 South & Central America Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Biopharmaceutical Companies
9.3.1 Overview
9.3.2 Biopharmaceutical Companies: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Contract Manufacturing Organizations
9.4.1 Overview
9.4.2 Contract Manufacturing Organizations: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10. South & Central America Bioproduction Market - Revenue and Forecast to 2030 - Country Analysis
10.1 South & Central America: Bioproduction Market
10.1.1 South & Central America: Bioproduction Market Share by Country - 2022 & 2030, (%)
10.1.1.1 Brazil: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2 Brazil: Bioproduction Market- Revenue and Forecasts to 2030 (US$ Million)
10.1.1.2.1 Brazil: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.2.2 Brazil: Bioproduction Market, By Application, 2020-2030 (US$ Million)
10.1.1.2.3 Brazil: Bioproduction Market, By Equipment, 2020-2030 (US$ Million)
10.1.1.2.3.1 Brazil: Bioproduction Market, for Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.2.4 Brazil: Bioproduction Market, By End User, 2020-2030 (US$ Million)
10.1.1.3 Argentina: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Overview
10.1.1.4 Argentina: Bioproduction Market- Revenue and Forecasts to 2030 (US$ Million)
10.1.1.4.1 Argentina: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.4.2 Argentina: Bioproduction Market, By Application, 2020-2030 (US$ Million)
10.1.1.4.3 Argentina: Bioproduction Market, By Equipment, 2020-2030 (US$ Million)
10.1.1.4.3.1 Argentina: Bioproduction Market, for Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.4.4 Argentina: Bioproduction Market, By End User, 2020-2030 (US$ Million)
10.1.1.5 Rest of South & Central America: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.1 Overview
10.1.1.6 Rest of South & Central America: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.1 Rest of South & Central America: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.6.2 Rest of South & Central America: Bioproduction Market, By Application, 2020-2030 (US$ Million)
10.1.1.6.3 Rest of South & Central America: Bioproduction Market, By Equipment, 2020-2030 (US$ Million)
10.1.1.6.3.1 Rest of South & Central America: Bioproduction Market, for Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.6.4 Rest of South & Central America: Bioproduction Market, By End User, 2020-2030 (US$ Million)
11. Bioproduction Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Bioproduction Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Lonza Group AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Danaher Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Sartorius AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Thermo Fisher Scientific Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Merck KGaA
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 F. Hoffmann-La Roche Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Bio-Rad Laboratories Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
List of Tables
Table 1. South & Central America Bioproduction Market Segmentation
Table 2. South & Central America Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 3. Brazil: Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 4. Brazil: Bioproduction Market, By Application - Revenue and Forecast to 2030 (US$ Million)
Table 5. Brazil: Bioproduction Market, By Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 6. Brazil: Bioproduction Market, for Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 7. Brazil: Bioproduction Market, By End User - Revenue and Forecast to 2030 (US$ Million)
Table 8. Argentina: Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 9. Argentina: Bioproduction Market, By Application - Revenue and Forecast to 2030 (US$ Million)
Table 10. Argentina: Bioproduction Market, By Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 11. Argentina: Bioproduction Market, for Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 12. Argentina: Bioproduction Market, By End User - Revenue and Forecast to 2030 (US$ Million)
Table 13. Rest of South & Central America: Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 14. Rest of South & Central America: Bioproduction Market, By Application - Revenue and Forecast to 2030 (US$ Million)
Table 15. Rest of South & Central America: Bioproduction Market, By Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 16. Rest of South & Central America: Bioproduction Market, for Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 17. Rest of South & Central America: Bioproduction Market, By End User - Revenue and Forecast to 2030 (US$ Million)
Table 18. Recent Inorganic Growth Strategies in the Bioproduction Market
Table 19. Recent Organic Growth Strategies in the Bioproduction Market
Table 20. Glossary of Terms, Bioproduction Market
List of Figures
Figure 1. South & Central America Bioproduction Market Segmentation, By Country
Figure 2. South & Central America Bioproduction Market: Key Industry Dynamics
Figure 3. South & Central America Bioproduction Market: Impact Analysis of Drivers and Restraints
Figure 4. South & Central America Bioproduction Market Revenue (US$ Mn), 2020 - 2030
Figure 5. South & Central America Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
Figure 6. Biologics and Biosimilars: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Vaccines: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Cell and Gene Therapies: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Nucleic Acid Therapeutics: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Others: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. South & Central America Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
Figure 12. Cancer: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Cardiovascular Diseases: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Rheumatoid Arthritis: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Hematological Disorders: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Diabetes: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. South & Central America Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
Figure 19. Consumables and Accessories: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Downstream Equipment: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Bioreactors: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Upstream Equipment: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. South & Central America Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
Figure 24. Biopharmaceutical Companies: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Contract Manufacturing Organizations: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Others: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. South & Central America: Bioproduction Market, By Key Country - Revenue (2022) (US$ Million)
Figure 28. South & Central America: Bioproduction Market Share by Country - 2022 & 2030, (%)
Figure 29. Brazil: Bioproduction Market- Revenue and Forecasts to 2030 (US$ Million)
Figure 30. Argentina: Bioproduction Market- Revenue and Forecasts to 2030 (US$ Million)
Figure 31. Rest of South & Central America: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Growth Strategies in the Bioproduction Market
1. Lonza Group AG
2. Danaher Corp
3. Sartorius AG
4. Thermo Fisher Scientific Inc
5. Merck KGaA
6. F. Hoffmann-La Roche Ltd
7. Bio-Rad Laboratories Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America bioproduction market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the South & Central America bioproduction market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America bioproduction market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.